TrialPloS one2021

A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.

Sendhilnathan Ramalingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.